Drug
CNM-Au8 clinical trials
How studies write it
Studies that test it under each name
Name
Studies by the year they started
8 studies that test it; most in 2020 (4)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 4 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 2
Often tested with
Tested in the same studies.
Zilucoplan (1) · AZD3241 (1) · Pridopidine (1) · SLS-005 (1) · Fosigotifator sodium tromethamine (1) · Fosigotifator (1) · Evetifator (1) · NUZ-001 (1)
Studies
Open first, then newest update. How each study uses CNM-Au8 is read from its arms, and is right about nine times in ten.
Testing it · 8
- HEALEY ALS Platform Trial - Master ProtocolActive, not recruitingPhase 2/3Merit E. Cudkowicz, MDNCT04297683Written as CNM-Au8
- 31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Multiple Sclerosis.CompletedPhase 2Clene NanomedicineNCT03993171Written as gold nanocrystals
- Therapeutic Nanocatalysis to Slow Disease Progression of Amyotrophic Lateral Sclerosis (ALS)CompletedPhase 2Clene NanomedicineNCT04098406Written as CNM-Au8
- 31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Parkinson's DiseaseCompletedPhase 2Clene NanomedicineNCT03815916Written as Gold Nanocrystals
- A Multi-Center, Open-Label Long-Term Extension Study of CNM-Au8 In Patients With Stable Relapsing Multiple SclerosisCompletedPhase 2/3Clene NanomedicineNCT04626921Written as CNM-Au8
- HEALEY ALS Platform Trial - Regimen C CNM-Au8CompletedPhase 2/3Merit E. Cudkowicz, MDNCT04414345Written as CNM-Au8
- Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple SclerosisTerminatedPhase 2Clene NanomedicineNCT03536559Written as CNM-Au8
- 31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Amyotrophic Lateral Sclerosis (REPAIR-ALS)WithdrawnPhase 2Clene NanomedicineNCT03843710Written as Gold Nanocrystals